Form 4: Phathom Pharmaceuticals Director Asit Parikh Reports Acquisition of Stock and Stock Options

Director Asit Parikh reports acquisition of 10,500 shares of common stock and 17,500 stock options in Phathom Pharmaceuticals.

Summary

• On May 23, 2024, Asit Parikh, a director of Phathom Pharmaceuticals, Inc. (PHAT), reported the acquisition of 10,500 shares of common stock.
• These shares were acquired through Restricted Stock Units (RSUs) granted under the Issuer's Non-Employee Director Compensation Program.
• Parikh also acquired 17,500 stock options with an exercise price of $10.30, also granted under the same program.
• The RSUs will vest on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, contingent upon continued service on the Board.
• Similarly, the stock options will vest and become exercisable on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, also contingent upon continued service on the Board.
• Following these transactions, Parikh beneficially owns 65,500 shares of common stock and 17,500 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option grants to a director, which is a common practice. It doesn't inherently indicate positive or negative sentiment, but rather aligns director interests with shareholders.

Positives

• The acquisition of stock and stock options by a director may signal confidence in the company's future prospects.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the director's continued service on the Board, aligning their interests with the company's long-term success.

Industry Context

Director stock ownership is a common practice in publicly traded companies to align the interests of management with shareholders. This Form 4 filing is a routine disclosure required by the SEC.

Stakeholder Impact

• The acquisition of shares and options by a director can be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates